European Archives - Page 652 of 1177 - European Medical Journal

Virtual GI Cancer Masterclass: Highlights in Gastrointestinal Cancers

Hear from a panel of renowned gastrointestinal cancers cancer experts, including chairperson Prof Eric van Cutsem (Belgium), Dr Elizabeth Smyth (UK)…

Extending Symptoms List Trigger Early Detection of COVID-19

DETECTION of SARS-CoV-2 infection through PCR eligibility triad symptoms of cough, fever, and loss of smell has been deemed ineffective by a group of…

Smart Safe Future with Emotion Detection AI Technology

AN EMOTION virtual recognition tracking system presented by a group of researchers from Incheon National University, South Korea could pave the way to…

Gastrointestinal Manifestations and Liver Injury: Correlation with Mortality and Clinical Outcomes in Patients with COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) arose in December 2019 in Wuhan, China, and was noted to cause a severe respiratory distress syndrome termed coronavirus disease (COVID-19)…

EMJ Podcast: Understanding Addiction

We explore our shifting attitudes towards addiction, consider the theory of ‘gateway drugs’, and assess why addiction and substance abuse has been on the rise during lockdown.

Was the pandemic the rebrand pharma needed?

The pharmaceutical industry has long struggled with its reputation, but 2020 offered an opportunity for reform. How has their response to the crisis affected perceptions, or is misinformation still getting in the way?

Securing patient care beyond COVID-19

While attention was channelled into COVID-19, patients awaiting other treatments were deprioritised. How can pharma ensure no patients are left behind?

Roundtable: a conversation about drug pricing

Hear from two thought leaders who share their passion for health economics, their thoughts on non-traditional models, and how they predict drugs will be costed in the future.

Can medical affairs help reduce health inequalities?

COVID-19 has revealed a pandemic of another kind: existing health inequities between population groups. We explore the role and responsibility of medical affairs teams in addressing imbalances and forging a fairer and more inclusive health landscape for the future

Finding a fast lane for precision medicine

What are the obstacles in the way of rolling out precision medicine and how can medical affairs professionals overcome them to fast-track adoption for patients?